MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Mobia Medical, Inc. (MOBI)

Mobia Medical, Inc. (MOBI)

||
||

Balance Sheets Overview

Current Ratio
1327.73%
Quick Ratio
1279.71%
Cash Ratio
1223.67%
Debt to Asset Ratio
11.61%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable
    • Other current assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Notes payable, net of discount a...
    • Others
Balance Sheets
2026-06-30
2026-03-31
Cash and cash equivalents
177,090
55,725
Accounts receivable
5,664
4,854
Inventory
6,949
6,049
Deferred offering costs
-
3,496
Other current assets
2,446
1,590
Total current assets
192,149
71,714
Property and equipment, net
2,060
738
Right-of-use assets - operating leases
932
1,001
Other assets
143
143
Total assets
195,284
73,596
Accounts payable
2,359
3,033
Operating lease liabilities, current
358
358
Product warranty liability
1,263
1,029
Accrued payroll, commissions, and bonuses
4,997
3,113
Accrued offering costs
3,500
2,641
Accrued and other current liabilities
1,995
1,660
Total current liabilities
14,472
11,834
Warrant liabilities
134
882
Notes payable, net of discount and deferred financing costs
7,279
7,257
Convertible notes payable-Nonrelated Party
-
14,359
Convertible notes payable-Related Party
-
26,369
Operating lease liabilities, non-current
790
870
Total liabilities
22,675
61,571
Redeemable convertible preferred issuable in series, stock, 0.01 par value, 67,174,403 shares authorized as of march 31, 2026 and december 31, 2025, respectively 65,591,701 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively aggregate liquidation value of 182,255 as of march 31, 2026 and december 31, 2025, respectively
-
179,773
Common stock, 0.01 par value, 950,000,000 and 86,600,000 shares authorized as of june 30, 2026 and december 31, 2025, respectively 33,286,108 and 884,030 shares outstanding as of june 30, 2026 and december 31, 2025, respectively
333
10
Additional paid-in capital
368,848
7,771
Accumulated deficit
-196,572
-175,529
Total stockholders' equity (deficit)
172,609
-167,748
Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit)
195,284
73,596
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$177,090K Inventory$6,949K Accounts receivable$5,664K Other current assets$2,446K Total current assets$192,149K Property and equipment,net$2,060K Right-of-use assets -operating leases$932K Other assets$143K Total assets$195,284K Total liabilities,redeemable convertible...$195,284K Total stockholders'equity (deficit)$172,609K Total liabilities$22,675K Accumulated deficit-$196,572K Additional paid-in capital$368,848K Total currentliabilities$14,472K Notes payable, net ofdiscount and deferred...$7,279K Operating leaseliabilities, non-current$790K Warrant liabilities$134K Common stock, 0.01 parvalue, 950,000,000 and...$333K Accrued payroll,commissions, and bonuses$4,997K Accrued offering costs$3,500K Accounts payable$2,359K Accrued and othercurrent liabilities$1,995K Product warrantyliability$1,263K Operating leaseliabilities, current$358K